Status:
COMPLETED
Study of BMN 110 in Pediatric Patients < 5 Years of Age With Mucopolysaccharidosis IVA (Morquio A Syndrome)
Lead Sponsor:
BioMarin Pharmaceutical
Conditions:
Mucopolysaccharidosis IVA
Morquio A Syndrome
Eligibility:
All Genders
Up to 5 years
Phase:
PHASE2
Brief Summary
This open-label Phase 2 study will evaluate the safety and efficacy of weekly 2.0 mg/kg/wk infusions of BMN 110 in pediatric patients, less than 5 years of age at the time of administration of the fir...
Eligibility Criteria
Inclusion
- Less than 5 years of age at the time of the first study drug infusion
- Documented clinical diagnosis of MPS IVA based on clinical signs and symptoms of MPS IVA and documented reduced fibroblast or leukocyte GALNS enzyme activity or genetic testing confirming diagnosis of MPS IVA
- Written informed consent provided by parent or legally authorized representative after the nature of the study has been explained and prior to any research-related procedures.
Exclusion
- Previous hematopoietic stem cell transplant (HSCT).
- Previous treatment with BMN 110.
- Known hypersensitivity to any of the components of BMN 110.
- Major surgery within 3 months prior to stuy entry or planned major surgery during the 52-week treatment period.
- Use of any investigational product or investigational medical device within 30 days prior to Screening, or requirement for any investigational agent prior to completion of all scheduled study assessments.
- Concurrent disease or condition, including but not limited to symptomatic cervical spine instability, clinically significant spinal cord compression, or severe cardiac disease that would interfere with study participation or safety as determined by the Investigator.
- Any condition that, in the view of the Investigator, places the subject at high risk of poor treatment compliance or of not completing the study.
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2016
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT01515956
Start Date
October 1 2011
End Date
February 1 2016
Last Update
August 10 2017
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Oakland, California, United States
2
Manhasset, New York, United States
3
Monza, Italy
4
Taipei, Taiwan